Nothing motivates us at PI more than seeing our partners succeed. So, when they hit milestones, we love to celebrate alongside them. Here’s a snapshot of what some of our partners have been achieving recently.
AutoIVF Inc.
AutoIVF’s foundational FIND-Chip technology was published in Nature Medicine. The clinical study reveals that more than 50% of IVF cases, functional oocytes are unintentionally missed during manual screening of the follicular fluid. This important discovery was enabled by their microfluidic FIND-Chip, the foundational technology behind our automated oocyte isolation and denudation system, OvaReady.
Quantum-SI Inc.
Two new manuscripts highlighting expanded applications for Quantum-Si‘s protein sequencing solution were recently published. The U.S. Naval Research Laboratory and Stanford University have uniquely demonstrated the power of having a benchtop next-gen protein sequencing instrument for clinical proteomics and complex real-world problems like pathogen and toxin detection.
Truvian Sciences Inc.
Truvian announced that they have received FDA clearance for 26 assays, including Complete Blood Count (CBC), on TruVerus™, their multimodal blood testing benchtop instrument designed to run chemistries, immunoassays, and hematology assays on a single device. TruVerus was built to transform how and when testing and care happens. By reducing complexity, lowering cost, and delivering comprehensive results from a small blood sample, TruVerus sets a new standard for decentralized care.
Vitrafy Life Sciences
Vitrafy showcased their Cryopreservation Ecosystem to cell and gene therapy leaders at Advanced Therapies Week in San Diego. They ran demos of the Guardion instrument, an LN₂-free, cryopreservation system that maintain high-quality biological materials from humans and animals (cells, blood products, semen, gametes, etc) by improving their freeze-thaw viability, traceability and scale-of-use.
